Compare Heron Therapeutics Inc (HRTX) vs Direxion Daily Semiconductor Bear 3X Shares (SOXS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Heron Therapeutics Inc trades at $0.37 (market cap $68.01M), while Direxion Daily Semiconductor Bear 3X Shares trades at $32.34 (market cap $1.96B). The key difference: Direxion Daily Semiconductor Bear 3X Shares is far larger — about 28.8× Heron Therapeutics Inc's market cap, and Direxion Daily Semiconductor Bear 3X Shares is more actively traded (113,512,541 versus 1,891,941). Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Direxion Daily Semiconductor Bear 3X Shares for 11 Days on average.
| HRTX | SOXS | |
|---|---|---|
Market Cap | $68.01M | $1.96B |
Volume | 1,891,941 | 113,512,541 |
Sector | Health | Leveraged / Inverse |
52-Week High | $1.49 | $988.00 |
52-Week Low | $0.27 | $29.62 |
Typical Hold Time | 35 Days | 11 Days |
Enterprise Value | $174.75M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) is trading at $0.39, up 17.58% today, with a bullish technical outlook from moving averages but mixed signals from oscillators. The company maintains strong gross margins of 70.07% but continues to report net losses, with Q2 2026 missing both EPS and revenue expectations. Analyst sentiment remains overwhelmingly positive with 89% buy ratings despite recent earnings disappointments and negative profitability metrics.
While analyst consensus is strongly bullish, HRTX faces significant fundamental challenges including consistent net losses, negative ROE of -78.72%, and cash flow concerns. The stock's current momentum appears driven by technical factors rather than improving fundamentals, creating a high-risk investment profile that requires careful monitoring of upcoming Q3 earnings and revenue stabilization efforts.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $30.645, up 3.43% today amid bearish technical signals. The ETF shows strong bearish momentum with moving averages indicating sell pressure, though oscillators are neutral. Recent news highlights SOXS as a tactical instrument for semiconductor sector declines, benefiting from AI stock volatility and chip sector weakness.
Outlook remains highly speculative given SOXS's inverse 3x leverage structure. Investment opportunity exists for short-term bearish semiconductor bets, but risks include extreme volatility, decay from daily reset, and persistent AI demand supporting chip stocks. This ETF is unsuitable for long-term holdings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Direxion Daily Semiconductor Bear 3X Shares
SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →
